iShares Nasdaq Biotechnology ETF (IBB)

Delayed Data
As of Dec 13
 +0.34 / +0.28%
Today’s Change
Today|||52-Week Range
IBB Regular Dividend: IBB will begin trading ex-dividend on 12/16/19 with a $0.0578 dividend payable to shareholders of record as of 12/17/19.

Investment Objective

The investment seeks to track the investment results of the NASDAQ Biotechnology Index, which contains securities of companies listed on NASDAQ that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq, Inc. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representing securities of the index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.

No recent news for iShares Nasdaq Biotechnology ETF.


1 month+8.99% 3 years+10.75%
3 months+15.61% 5 years+3.53%
1 year+14.30% Since inception+7.21%
Data through 12/13/2019

Quote Details

Previous close$120.29
Open day’s range119.89 – 122.00
Net asset value (NAV)120.37 (12/12/2019)
Daily volume2,852,001
Average volume (3 months)2,416,805
Data as of 4:00pm ET, 12/13/2019

Peer Comparisonvs. Health ETFs

Performance 5-yr return+3.53%+7.05%
Expense Gross exp ratio0.47%1.25%
Risk 5 year sharpe ratio0.220.48
Net assets$7.9B$3.2B
Average market cap$12.4B$40.0B
Average P/E19.126.1
Dividend / Share--0.27%


VHT Vanguard Health Care Index Fund ETF Shar...
FHLC Fidelity MSCI Health Care Index ETF
IXJ iShares Global Healthcare ETF


Top 5 Sectors
Portfolio weighting
Healthcare 99.91%
Business service 0.09%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
AMGN Amgen8.44%
GILD Gilead Sciences7.94%
VRTX Vertex Pharmaceuticals Inc7.43%
ILMN Illumina Inc6.15%
BIIB Biogen5.12%
REGN Regeneron Pharmaceuticals4.77%
ALXN Alexion Pharmaceuticals Inc3.45%
SGEN Seattle Genetics Inc2.77%
INCY Incyte Corp2.74%
BMRN Biomarin Pharmaceutical Inc1.96%